DE69702209T2 - Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie - Google Patents

Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie

Info

Publication number
DE69702209T2
DE69702209T2 DE69702209T DE69702209T DE69702209T2 DE 69702209 T2 DE69702209 T2 DE 69702209T2 DE 69702209 T DE69702209 T DE 69702209T DE 69702209 T DE69702209 T DE 69702209T DE 69702209 T2 DE69702209 T2 DE 69702209T2
Authority
DE
Germany
Prior art keywords
diagnosis
eclampsia
preclampsy
therapy
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69702209T
Other languages
English (en)
Other versions
DE69702209D1 (de
Inventor
William Rademacher
Patricia Mclean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Rademacher Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rademacher Group Ltd filed Critical Rademacher Group Ltd
Application granted granted Critical
Publication of DE69702209D1 publication Critical patent/DE69702209D1/de
Publication of DE69702209T2 publication Critical patent/DE69702209T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
DE69702209T 1996-09-11 1997-09-11 Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie Expired - Lifetime DE69702209T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9618931.1A GB9618931D0 (en) 1996-09-11 1996-09-11 Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
PCT/GB1997/002534 WO1998010791A1 (en) 1996-09-11 1997-09-11 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes

Publications (2)

Publication Number Publication Date
DE69702209D1 DE69702209D1 (de) 2000-07-06
DE69702209T2 true DE69702209T2 (de) 2000-11-09

Family

ID=10799739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69702209T Expired - Lifetime DE69702209T2 (de) 1996-09-11 1997-09-11 Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie

Country Status (14)

Country Link
US (2) US6495330B1 (de)
EP (1) EP0939651B1 (de)
JP (1) JP4457191B2 (de)
CN (1) CN1146445C (de)
AT (1) ATE193452T1 (de)
AU (1) AU715884B2 (de)
BR (1) BR9711752A (de)
CA (1) CA2264939C (de)
DE (1) DE69702209T2 (de)
DK (1) DK0939651T3 (de)
ES (1) ES2148967T3 (de)
GB (1) GB9618931D0 (de)
IL (1) IL128893A0 (de)
WO (1) WO1998010791A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
GB9801899D0 (en) * 1998-01-29 1998-03-25 Univ London Neurotrophic properties of ipgs analogues
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies
EP1062246A1 (de) * 1998-03-18 2000-12-27 Rademacher Group Limited Anti-inositolphosphoglycan monoklonale antikörper
GB9806645D0 (en) * 1998-03-27 1998-05-27 Univ London Materials and methods relating to the treatment of conditions involving mast cells,basophils and eosinophils
GB9828564D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Materials and methods for the treatment and diagnosis of cancer
GB9914326D0 (en) * 1999-06-18 1999-08-18 Rademacher Group Limited Materials and methods relating to the diagnosis and treatment of pre-eclampsia
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
WO2001085746A1 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
WO2001086292A2 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceutical Limited Ipg assay
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
WO2001085745A1 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
GB0015625D0 (en) * 2000-06-26 2000-08-16 Univ London Materials and methods relating for the treatment and diagnosis of pre-eclampsia
BRPI0407213A (pt) * 2003-02-04 2006-02-07 Univ Tulane Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
MX2007003522A (es) * 2004-09-24 2007-06-11 Beth Israel Hospital Complicaciones del embarazo.
CA2751679C (en) 2009-02-06 2018-02-27 Women & Infants' Hospital Of Rhode Island Compositions for treating preeclampsia-type disorders of pregnancy comprising transthyretin
AU2019226355A1 (en) * 2018-02-28 2020-09-17 Pharming Intellectual Property B.V. Treatment and prevention of pre-eclampsia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2113344T3 (es) * 1989-08-03 1998-05-01 Univ California Metodo para aislar celulas de citotrofoblastos fetales.
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies

Also Published As

Publication number Publication date
GB9618931D0 (en) 1996-10-23
CA2264939C (en) 2012-06-05
ATE193452T1 (de) 2000-06-15
JP4457191B2 (ja) 2010-04-28
JP2001501598A (ja) 2001-02-06
AU4310297A (en) 1998-04-02
US6495330B1 (en) 2002-12-17
EP0939651A1 (de) 1999-09-08
CN1235556A (zh) 1999-11-17
EP0939651B1 (de) 2000-05-31
CA2264939A1 (en) 1998-03-19
WO1998010791A1 (en) 1998-03-19
IL128893A0 (en) 2000-01-31
DK0939651T3 (da) 2000-09-04
AU715884B2 (en) 2000-02-10
US20030091581A1 (en) 2003-05-15
ES2148967T3 (es) 2000-10-16
CN1146445C (zh) 2004-04-21
BR9711752A (pt) 2000-01-18
DE69702209D1 (de) 2000-07-06

Similar Documents

Publication Publication Date Title
DE69702209D1 (de) Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie
EP0975374A4 (de) Radiometall-bindende peptide analoge
EP0738125A4 (de) Verfahren und vorrichtung zur behandlung krankhafter veränderungen des kreislaufsystems
MX9803253A (es) Metodo para el tratamiento de colitis establecida utilizando anticuerpos contra il-12.
TR199800091T1 (xx) Ba����kl�k hastal�klar�n�n tedavisi i�in terap�tik maddeler olarak kullan�lan ��z�nebilir lenfotoksin-� resept�rleri ve anti-lenfotoksin resept�r� ve ligand� antikorlar�.
ATE338818T1 (de) Verfahren zur diagnose des glaukoms
ATE315654T1 (de) Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
IL172185A0 (en) Method of diagnosis lung damage
DE69735436D1 (de) Methode zum nachweis von zell-apoptose
DE69635998D1 (de) Nachweisverfahren für verbindungen, welche die somatostatin- und insulinproduktion stimulieren
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
DE59008975D1 (de) Verfahren zum überwachen von anlagen, wie autokrane, grossbagger oder dergleichen, und system zur verwirklichung dieses verfahrens.
DE3779612D1 (de) Verfahren zum testen eines modifizierten booth-multiplizierers, modifizierter booth-multiplizierer, geeignet zum testen mittels dieses verfahrens, und denselben enthaltende integrierte schaltung.
DE3765613D1 (de) Verfahren und vorrichtung zum herstellen von mit hinterschaeumten bezuegen versehenen polstern, insbesondere automobilsitzpolstern.
ATE477504T1 (de) Auf nmr basiertes verfahren zum erkennen von liganden, wobei ligand oder ziel hyperpolarisiert sind und das nmr-spektrum mit einem referenzspektrum des liganden oder ziels verglichen wird
ATE178074T1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
ES2191173T3 (es) Anticuerpos monoclonales contra un complejo de act humana y una proteasa de serina.
DE69610411T2 (de) Verfahren zur trennung von p-xylol, das eine vorbehandlung durch selektive hydrierung und eine behandlung mit aktiver erde umfasst
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
ATE546544T1 (de) Verfahren zur diagnose und behandlung von lungenkrebs
ATE228250T1 (de) Diagnosehilfe sowie verfahren zum nachweis der trächtigkeit von wiederkäuern
MX9603966A (es) Metodo de seleccion empleando la familia del receptor rzr.
KUBO et al. Urban Landscape Planning and Design Determination of Urban Landscape Identities in Sakai
DE58904746D1 (de) Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: RODARIS PHARMACEUTICALS LTD., OXFORD, GB

8327 Change in the person/name/address of the patent owner

Owner name: SR PHARMA PLC, LONDON, GB